Synthesis and characterization of cross-linked malonylchitosan microspheres for controlled release of acyclovir

被引:37
作者
Stulzer, Hellen Karine [1 ,2 ]
Lacerda, Loreana [1 ]
Tagliari, Monika P. [2 ]
Silva, Marcos A. S. [2 ]
Favere, Valfredo T. [1 ]
Laranjeira, Mauro C. M. [1 ]
机构
[1] Univ Fed Santa Catarina, Lab Quitech, Dept Quim, BR-88040900 Florianopolis, SC, Brazil
[2] Univ Fed Santa Catarina, Lab Controle Qualidade, Dept Ciencias Farmaceut, BR-88040900 Florianopolis, SC, Brazil
关键词
acyclovir; chitosan microspheres; controlled release;
D O I
10.1016/j.carbpol.2007.12.012
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
The purpose of the present study was to obtain a polymeric system for delayed release of the drug acyclovir (ACV), which call be used for treatment of Herpes simplex and Varicella Zoster. The gelled chitosan (GCT) microspheres were obtained by coacervation-phase separation. They were treated with malonic acid to obtain malonylchitosan (MLCT) microspheres, which were characterized by, Fourier transform infrared spectroscopy (FT-IR), nuclear magnetic resonance spectroscopy (C-13 NMR), elemental analysis (CHN), thermogravimetric analysis (TG/DTG) and scanning electron microscopy (SEM). The drug was encapsulated in MLCT microspheres by a contact adsorption technique, and the final formulation (MLCT-ACV), was analyzed for loading efficiency, degree of swelling and in vitro release profiles. The results obtained support the N-substitution of malonyl groups in the MLCT microspheres. The loading efficiency increased with impregnation time and a major amount of drug was encapsulated after 24 h. The swelling rate was higher in acid pH. The median release time was 5.5 h in pH 1.2 and 6.8. The mechanism involved in release was non-Fickian (0.43 < n < 0.85, n = 0.8474) and Super Case II kinetics (n > 1, n = 1.0491) at pH 1.2 and 6.8, respectively. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:490 / 497
页数:8
相关论文
共 29 条
[1]   A novel pH-sensitive hydrogel composed of N,O-carboxymethyl chitosan and alginate cross-linked by genipin for protein drug delivery [J].
Chen, SC ;
Wu, YC ;
Mi, FL ;
Lin, YH ;
Yu, LC ;
Sung, HW .
JOURNAL OF CONTROLLED RELEASE, 2004, 96 (02) :285-300
[2]  
Cheu SJ, 2001, J MICROENCAPSUL, V18, P559
[3]   Biodegradable microspheres for the intravitreal administration of acyclovir: in vitro in vivo evaluation [J].
Conti, B ;
Bucolo, C ;
Giannavola, C ;
Puglisi, G ;
Giunchedi, P ;
Conte, U .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 5 (05) :287-293
[4]   Modeling and comparison of dissolution profiles [J].
Costa, P ;
Manuel, J ;
Lobo, S .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 13 (02) :123-133
[5]   Preparation of cross-linked chitosan microspheres by spray drying: Effect of cross-linking agent on the properties of spray dried microspheres [J].
Desai, KGH ;
Park, HJ .
JOURNAL OF MICROENCAPSULATION, 2005, 22 (04) :377-395
[6]   Pharmaceutical applications of chitosan [J].
Dodane, V ;
Vilivalam, VD .
PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY, 1998, 1 (06) :246-253
[7]  
GIAMMONA G, 1995, J CONTROL RELEASE, V33, P261, DOI 10.1016/0168-3659(94)00091-8
[8]   Chitosan microparticles containing plasmid DNA as potential oral gene delivery system [J].
Guliyeva, U ;
Öner, F ;
Özsoy, S ;
Haziroglu, R .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2006, 62 (01) :17-25
[9]   Selective separation of germanium(IV) by 2,3-dihydroxypropyl chitosan resin [J].
Inukai, Y ;
Chinen, T ;
Matsuda, T ;
Kaida, Y ;
Yasuda, SJ .
ANALYTICA CHIMICA ACTA, 1998, 371 (2-3) :187-193
[10]  
JALON EG, 2001, J CONTROL RELEASE, V75, P191